Metformin, the usual first choice medication, said to lead the pack.
THURSDAY, April 7 (HealthDay News) -- The commonly used oral diabetes drug metformin not only helps stabilize blood sugar levels, it also may offer protection against heart disease, researchers say.
In a study that included more than 100,000 residents of Denmark taking metformin or another group of oral diabetes medications called insulin secretagogues (ISs), researchers found that metformin and the IS drugs gliclazide and repaglinide had the lowest risk of cardiovascular disease and death.
"Some medications, such as metformin, gliclazide and repaglinide, are more effective in reducing cardiovascular risk than the other medications," said Dr. Tina Ken Schramm, a senior resident at Copenhagen University Hospital in Denmark.
Dr. Darren McGuire, co-author of an editorial accompanying the study, agreed and said...
Read more by clicking on http://www.healthfinder.gov/news/newsstory.aspx?docID=651695
No Comments
You need to
register to comment.